Clinical Trial: NRG CCTG-PR24

NRG CCTG-PR24

Status: Open

Androgen Suppression Combined with Elective Nodal Irradiation and Dose Escalated Prostate Treatment: A Non-Inferiority, Phase III Randomized Controlled Trial of Stereotactic Body Radiation Therapy Versus Brachytherapy Boost in Patients with Unfavorable Risk Localized Prostate Cancer (ASCENDE-SBRT)

Eligible for screening study DCP 001

 Completion of Pre-Registration QOLs is required after consent, prior to registration. Please see study documents.